| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |